Table 1.
Binding of phage antibodies by subsets of fetal liver cells
| Antibody fragment/mAb* | Light-density
fetal liver
|
GPA− light-density fetal liver
|
||
|---|---|---|---|---|
| GPA+ | GPA− | CD34+ | CD34− | |
| Cluster A | ||||
| FSH8 | 90.9% | 16.9% | 6.6% | 5.3% |
| FSH7 | 92.1% | 39.6% | 2.0% | 3.9% |
| FSG5 | 98.7% | 66.7% | 7.0% | 6.7% |
| FSG9 | 86.2% | 45.7% | 3.1% | 4.2% |
| Cluster B | ||||
| C7 | 71.6% | 7.5% | 5.5% | 4.8% |
| F4 | 81.7% | 9.8% | 5.4% | 4.6% |
| C3 | 84.1% | 7.9% | 7.1% | 6.5% |
| B5 | 88.0% | 8.0% | 9.9% | 8.7% |
| Cluster C | ||||
| FSE2 | 99.2% | 46.9% | 18.4% | 8.2% |
| A6 | 81.6% | 11.3% | 14.8% | 6.2% |
| CD36* | 98.4% | 34.6% | 43.2% | 25.7% |
| FSH3 | 90.7% | 22.0% | 22.9% | 18.9% |
| FSD8 | 99.2% | 53.6% | 53.7% | 51.5% |
| CD71* | 99.2% | 47.8% | 52.0% | 13.7% |
| FSA7 | 97.9% | 30.3% | 42.8% | 20.0% |
| FSD10 | 99.4% | 51.3% | 45.0% | 18.0% |
| H7 | 99.3% | 71.5% | 61.9% | 23.0% |
| G4 | 99.1% | 34.0% | 39.0% | 13.8% |